Newton, MA, United States of America

Joel Bard

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 8.9

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovations of Joel Bard

Introduction

Joel Bard is an accomplished inventor based in Newton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 4 patents to his name, Bard's work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents are the "Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof." This invention provides antibodies, or antigen-binding fragments thereof, which specifically bind to tumor necrosis factor (TNF)-like ligand (TL1A). The invention further details a method of obtaining such antibodies and nucleic acids encoding the same. Additionally, it relates to compositions and therapeutic methods for the use of these antibodies in the treatment and/or prevention of TL1A mediated diseases, disorders, or conditions. Another similar patent focuses on "Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof," emphasizing the importance of these antibodies in medical applications.

Career Highlights

Throughout his career, Joel Bard has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Bristol-Myers Squibb Company. His experience in these organizations has allowed him to refine his expertise in drug development and therapeutic innovations.

Collaborations

Joel has collaborated with notable professionals in his field, including Robert Arch and Jun Zhang. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Joel Bard's innovative work in the field of biotechnology, particularly in the development of therapeutic antibodies, showcases his significant contributions to medical science. His patents and collaborations reflect a commitment to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…